$RYM

Vakili Armon sold $60K of RYM

Vakili Armon sold 2,250 shares of RYTHM, Inc. (RYM) at an average of $26.52 ($25.00–$27.17) across 3 trades on 2026-06-17.

Original reporting
SEC EDGAR · Vakili Armon
Published Jun 18, 2026, 8:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$RYM
Neutral
medium confidence
Mentioned
$RYM
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RYMNeutralLow
01

Why it matters

A director’s open-market sale is disclosed with trade dates, share counts, and post-transaction holdings, but no accompanying corporate action or guidance change is provided.

02

Market read

Traders may monitor for follow-on insider activity, but this single sale is unlikely to drive a fundamental repricing by itself.

03

What to watch

Insider sales often occur for diversification/tax/estate planning; without context on prior sales frequency or option exercises, directional inference is weak.

Relevance 3/10Novelty 5/10Timing: Filed 2026-06-18; sale executed 2026-06-17

Background

The article is an SEC Form 4 insider transaction disclosure for RYTHM, Inc. (RYM).

Company-level read

Ticker impact

$RYMNeutralMedium confidence
Context

SEC Form 4 shows director Vakili Armon sold $59,675.75 of RYM shares in open-market trades on 2026-06-17.

Expected impact

Likely limited near-term impact; treat as low-signal unless repeated or paired with other disclosures.

Evidence & confidence

The filing is a primary-source insider transaction, but it is a relatively small dollar amount versus typical market cap moves and provides no operational or guidance change.

Market effects

Minimal—this is company-specific insider activity with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is not explicitly tied to a 10b5-1 plan, it could reflect liquidity needs rather than bearish conviction; repeated sales would matter more than one print.

Key entities

  • Vakili Armon

    Director of RYTHM, Inc. who sold shares via open-market transactions.

  • RYTHM, Inc.

    Company whose shares were sold; insider transaction disclosed on SEC EDGAR.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$GTBIFMed

Green Thumb Amends RYTHM Notes and Warrants, Removes Ownership Cap; $72M Notes Affected

Green Thumb Industries (GTBIF) amended its secured convertible notes, pre-funded warrants, and shared services agreement with RYTHM to remove a 49.99% beneficial ownership cap. The amendment affects $72.0M of original principal and warrants for up to 9,731,638 shares, effective Oct 10, 2026. Green Thumb will consolidate RYTHM from that date, without intending to exercise the securities.

$RYMMed

RYTHM, Inc. (RYM): Results of Operations and Financial Condition

RYTHM, Inc. (RYM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 RYTHM, Inc. Reports Second Quarter 2026 Results ROLLING MEADOWS, IL, August 4, 2026 (GLOBE NEWSWIRE) – RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company whose portfolio of trusted THC brands includes RYTHM, Señorita, incredibles, Beboe, and

$RYMMedAI 8/10

Daily NZX update, Friday, June 5, 2026

NZX 50 was up 0.3% at 3:00pm, though down 0.5% over five days and 2.6% over six months. Top gainers included Air New Zealand (+2%), Mainfreight (+2%) and Genesis Energy (+2%); biggest fallers were Kathmandu (-3%), A2 Milk (-2%) and Tourism Holdings (-2%). SmartShares ETFs were mixed. Meridian welcomed a draft Fast-track Panel decision on Lake Pūkaki access; Infratil completed a $200m capital bond offer; Ryman reported FY26 EBITDAF $88.3m and free cash flow $188.3m.

$RYMMedAI 8/10

Daily NZX update, Wednesday, June 3, 2026

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.